VIENNA--(BUSINESS WIRE)--Themis, a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer and MSD (trademark of Merck & Co ...
MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced its intention to acquire the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback